⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AGIO News
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact The Gross Law Firm for Details- AGIO
prnewswire.com
AGIO
Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO
prnewswire.com
AGIO
Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO
prnewswire.com
AGIO
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
globenewswire.com
AGIO
More Than 30 Million Americans Living with Rare Diseases
prnewswire.com
AMGN
SNY
AGIO
ASND
DVA
INCY
NVS
PFE
REGN
UCB
Cancer Stress Protein Helps Tumors Hide From Immunity
prnewswire.com
PFE
BMY
KYMR
AGIO
BDTX
PRTA
Sickle Cell Disease Competitive Landscape Report 2026: Comprehensive Analysis of Over 40 Companies and More Than 50 Drugs
globenewswire.com
NVS
PFE
AGIO
CRSP
TAK
Netrio Expands Belfast Office to Further International Growth
prnewswire.com
AGIO
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
AGIO
Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
globenewswire.com
AGIO